All Stories

  1. Risk of neuroblastoma, maternal characteristics and perinatal exposures: The SETIL study
  2. SETIL: Italian multicentric epidemiological case–control study on risk factors for childhood leukaemia, non hodgkin lymphoma and neuroblastoma: study population and prevalence of risk factors in Italy
  3. The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors
  4. Intensive Care Unit Admission in Children With Malignant or Nonmalignant Disease
  5. Small intestinal bacterial overgrowth and cystic fibrosis: Epidemiology, clinical impact and efficacy of rifaximin therapy
  6. Practices of pediatric oncology and hematology providers regarding fertility issues: A European survey
  7. Role of Acute Graft-Versus-Host Disease in the Risk of Bacteremia and Invasive Fungal Disease after Allogeneic Hemopoietic Stem Cell Transplantation in Children. Results from a Single-Center Observational Study
  8. Central Diabetes Insipidus in Children and Young Adults: Etiological Diagnosis and Long-Term Outcome of Idiopathic Cases
  9. Neuroblastoma with symptomatic epidural compression in the infant: The AIEOP experience
  10. Role of Management Strategies in Reducing Mortality From Invasive Fungal Disease in Children With Cancer or Receiving Hemopoietic Stem Cell Transplant
  11. Seasonal variations of date of diagnosis and birth for neuroblastoma patients in Italy
  12. Administration schedule and ototoxicity of amikacin in children with cancer
  13. Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience
  14. Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on
  15. Ciprofloxacin Prophylaxis in Children With Acute Leukemia in an Era of Increasing Antibiotic Resistance
  16. Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma
  17. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years
  18. Risk of repeated febrile episodes during chemotherapy-induced granulocytopenia in children with cancer: a prospective single center study
  19. Bone Marrow-Infiltrating Human Neuroblastoma Cells Express High Levels of Calprotectin and HLA-G Proteins
  20. Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial
  21. Epidemiology of Febrile Neutropenia in Children With Central Nervous System Tumor
  22. Invasive mould infections in newborns and children
  23. Guidelines for the management of bacterial and fungal infections during chemotherapy for pediatric acute leukemia or solid tumors: what is available in 2010?
  24. Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors
  25. Magnetic resonance imaging in childhood leukemia survivors treated with cranial radiotherapy: A cross sectional, single center study
  26. Appreciation and the Interdisciplinary Management of the Psychosocial Impact of Leukemia on Children and Their Families
  27. Incidence of bacteremias and invasive mycoses in children with acute non-lymphoblastic leukemia: Results from a multi-center Italian study
  28. MDM2 SNP309 genotype is associated with ferritin and LDH serum levels in children with stage 4 neuroblastoma
  29. Detection of cell-free RNA in children with neuroblastoma and comparison with that of whole blood cell RNA
  30. Outcome of children with neuroblastoma after progression or relapse. A retrospective study of the Italian neuroblastoma registry
  31. Natural course of HCV infection in childhood cancer survivors
  32. Osteochondroma after Hematopoietic Stem Cell Transplantation in Childhood. An Italian Study on Behalf of the AIEOP-HSCT Group
  33. Renal outcome in patients with congenital anomalies of the kidney and urinary tract
  34. MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma
  35. Is intensive follow-up for early detection of tumors effective in children with Beckwith-Wiedemann syndrome?
  36. Survival of children with cancer in Italy, 1989–98. A report from the hospital based registry of the Italian Association of Paediatric Haematology and Oncology (AIEOP)
  37. Long term survivors of childhood cancer: Cure and care
  38. The prognostic role of urinary catecholamines in infants with disseminated neuroblastoma may be mediated by MYCN amplification
  39. Incidence of bacteremias and invasive mycoses in children with high risk neuroblastoma
  40. Fungal Infections in Children With Cancer
  41. Neuroblastoma in adolescents
  42. Survival after relapse in children with solid tumors: A follow-up study from the Italian off-therapy registry
  43. Incidence of catheter-related infections within 30 days from insertion of Hickman–Broviac catheters
  44. Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant
  45. Malignant neuroblastic tumors in adolescents
  46. HCV Infection in Very-Long-Term Survivors After Cancer Chemotherapy and Bone Marrow Transplantation
  47. Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: A 13-year experience at a single Italian institution
  48. Glutathione S-transferase polymorphisms and susceptibility to neuroblastoma
  49. Correlation between “malfunctioning events” and catheter-related infections in pediatric cancer patients bearing tunneled indwelling central venous catheter: results of a prospective observational study
  50. Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy
  51. Role of active follow-up for early diagnosis of relapse after elective end of therapies
  52. The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity
  53. Urokinase for restoring patency of malfunctioning or blocked central venous catheters in children with hemato-oncological diseases
  54. A single institution observational study of early mechanical complications in central venous catheters (valved and open-ended) in children with cancer
  55. Homozygosis for (12) CA repeats in the first intron of the human IFN-γ gene is significantly associated with the risk of aplastic anaemia in Caucasian population
  56. Permanent consequences in Langerhans cell histiocytosis patients: A pilot study from the Histiocyte Society?Late Effects Study Group
  57. Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia
  58. A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma
  59. Parotid Carcinoma After Autologous Bone Marrow Transplantation for Relapsed Nephroblastoma
  60. Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemia
  61. Second malignancies in children with neuroblastoma after combined treatment with131I-metaiodobenzylguanidine
  62. Helicobacter pylori-Associated Large Gastric Ulcer During Treatment for Childhood Leukemia
  63. Interferon γ and tumour necrosis factor α are overexpressed in bone marrow T lymphocytes from paediatric patients with aplastic anaemia
  64. Langerhans cell histiocytosis in two generations: A new family and review of the literature
  65. Early occurence of a secondary thyroid carcinoma in a child treated for Hodgkin disease
  66. Langerhans cell histiocytosis in two generations: A new family and review of the literature
  67. Non-identical twin sisters concordant for Langerhans cell histiocytosis and discordant for secondary acute promyelocytic leukemia
  68. Early and late deaths after elective end of therapies for childhood cancer in Italy
  69. Early and late deaths after elective end of therapies for childhood cancer in Italy
  70. Familial clustering of Langerhans cell histiocytosis
  71. Risk of secondary leukemia after treatment with etoposide VP-16) for Langerhans cell histiocytosis in Italian and Austrian-German populations
  72. Can protocol-specified doses of chemotherapy and radiotherapy be used as a measure of treatment actually received? A CCG/NIH study on long-term survivors of acute lymphocytic leukemia
  73. Diamond-Blackfan anemia and malignancy: A case report and a review of the literature
  74. THE HEALTH STATUS OF ADULTS TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) DURING CHILDHOOD. • 945
  75. Second malignant tumors after elective end of therapy for a first cancer in childhood: A multicenter study in Italy
  76. Educational Attainment in Long-term Survivors of Childhood Acute Lymphoblastic Leukemia
  77. Increased Risk of Secondary Leukemia After Single-Agent Treatment with Etoposide for Langerhans' Cell Hlstlocytosls
  78. Acute Myeloid Leukemia After Single-Agent Treatment with Etoposide for Langerhansʼ Cell Histiocytosis of Bone
  79. Neuroblastoma IV-S in a patient with bilateral microphthalmia
  80. Outcome after cessation of therapy in childhood acute lymphoblastic leukaemia
  81. Pentasomy 21 in leukemia complicating Diamond-Blackfan anemia
  82. Karyotype evolution in a patient with biphenotypic neonatal leukemia
  83. Wilms' Tumor After Treatment
  84. Smoking habits in survivors of childhood and adolescent cancer
  85. Secondary acute promyelocytic leukemia with t(8;21) and t(9;22) at onset and loss of the philadelphia chromosome at relapse
  86. Congenital Leukemia: Persistent Spontaneous Regression in a Patient with an Acquired Abnormal Karyotype
  87. ins(6;1) in a patient with congenital leukemia
  88. Italian registry of patients off therapy after childhood acute lymphoblastic leukemia. Results after first phase of data collection
  89. Control of pain with sublingual buprenorphine in children with cancer
  90. Immune evaluation of 50 children with neuroblastoma at onset